• 作者：Joaquí ; n Cardona^a ; ^b ; Enrique Rodilla^a ; ^b ; José ; Marí ; a Pascual^a ; ^b ; ^c ; ^{pascual_jma@gva.es}
• 关键词：Dislipemia ; Mujeres ; VIH ; Ancianos ; Enfermedad renal cr&oacute ; nica ; Sí ; ndrome metab&oacute ; lico
• 刊名：Revista Espa?ola de Cardiolog篓陋a Suplementos
• 出版年：2011
• 期刊代码：pca309_11313587
• 类别：med
• 出版时间：2011
• 卷：11
• 期：supp_S2
• 页码：36-41
• 文件大小：88 K

There is still some disagreement about how dyslipidemia should be treated in particular population groups. This article provides a review of indications for lipid-lowering treatment, preferably for primary prevention, in specific groups of patients: women, the elderly, and those with an HIV infection, chronic kidney disease or metabolic syndrome. Special emphasis is placed on data obtained in the JUPITER trial and in other studies of rosuvastatin.